Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study for the Transfer of Bone Marrow-Derived Mononuclear and Mesenchymal StemCells Into the Myocardium for the Treatment of Severe Coronary Ischemia

NCT00790764 is registered in ClinicalTrials.gov with TCA Cellular Therapy as lead sponsor.

NCT NCT00790764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00790764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study for the Transfer of Bone Marrow-Derived Mononuclear and Mesenchymal StemCells Into the Myocardium for the Treatment of Severe Coronary Ischemia
Lead sponsor
TCA Cellular Therapy
Phase
Phase 2
Overall status
Suspended
Start date
November 30, 2008
Completion date
May 31, 2014
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blocked arteries, coronary artery disease, coronary atherosclerosis, coronary disease, coronary ischemia, heart disease